Role of the immuno-proteasome in CD8 responses to MCMV

Role of the immuno-proteasome in CD8 responses to MCMV

Bibliographic Details
Main Author:	Hutchinson, SL
Other Authors:	Klenerman, P
Format:	Thesis
Language:	English
Published:	2009
Subjects:	Immunology Infectious diseases Viruses

Similar Items

Function, phenotype and development of human CD161+CD8 T cells
by: Walker, LJ
Published: (2012)

Characterisation of tissue homing CD8+ T cells in a murine cytomegalovirus model
by: O'Hara, G
Published: (2013)

Immunodominant CD8+ T cell responses to HIV-1 infection - 'The good and the bad'
by: Culshaw, A
Published: (2011)

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells
by: Shirin Nkongolo, et al.
Published: (2023-01-01)

The role of DOCK8 in the maintenance of CD8+ T cell memory and invariant NKT cells
by: Crawford, G
Published: (2012)

Memory T cell responses in influenza A infection and vaccination in humans
by: Chui, C
Published: (2012)

A study of the phenotype and function of HLA-C restricted CD8 T cells in HIV-1 infection
by: Corrah, TW
Published: (2011)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
by: Alharbi, N
Published: (2014)

The role of autophagy in CD8+ T cell immunity
by: Puleston, D, et al.
Published: (2015)

A systematic analysis of the human immune response to Plasmodium vivax
by: Florian A. Bach, et al.
Published: (2023-10-01)

Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis
by: Deepika Awasthi, et al.
Published: (2023-09-01)

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
by: Charlotte Thibeault, et al.
Published: (2023-04-01)

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
by: McNaughton, AL, et al.
Published: (2022)

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
by: Anna L. McNaughton, et al.
Published: (2022-07-01)

Anti–miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response
by: Mihnea P. Dragomir, et al.
Published: (2023-10-01)

mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
by: Satomi Ando, et al.
Published: (2023-01-01)

Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection
by: Eleanor C. Semmes, et al.
Published: (2022-08-01)

The impact of host and therapy mediated selection on HIV-1 evolution
by: Huang, K
Published: (2010)

Identification of immunological targets for HIV-1 vaccine and cure strategies
by: Hancock, G
Published: (2014)

Natural and therapy-induced immune control of HIV-1
by: Yager, N
Published: (2011)

Contribution of monocytes to immunopathology during influenza A virus infection
by: Cole, S, et al.
Published: (2014)

Characterisation of the HIV-1 reservoir and the potential for viral eradication
by: Williams, J, et al.
Published: (2014)

Characterisation of expression and function of respiratory epithelial CD1d
by: Hajipouran Benam, K
Published: (2014)

Functional impact of CD161 on T cells
by: Smith, K
Published: (2013)

Molecular profiling CD8+ T-cell memory inflation
by: Sims, S, et al.
Published: (2013)

Implications of HCV genotype 3 specific immunity on cross-reactive vaccine design
by: von Delft, A, et al.
Published: (2014)

The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis
by: Nadine Althof, et al.
Published: (2018-02-01)

Assessment of anti-merozoite antibody function in the context of blood-stage malaria vaccine development
by: Llewellyn, D
Published: (2014)

MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival
by: C. Korin Bullen, et al.
Published: (2023-10-01)

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza
by: Hillary A. Vanderven, et al.
Published: (2023-07-01)

Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations
by: Jennifer R. Habel, et al.
Published: (2023-04-01)

Potently neutralizing human mAbs against the zoonotic pararubulavirus Sosuga virus
by: Helen M. Parrington, et al.
Published: (2023-04-01)

Ebola virus protein VP40 stimulates IL-12– and IL-18–dependent activation of human natural killer cells
by: Hung Le, et al.
Published: (2022-08-01)

ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission
by: Eleanor C. Semmes, et al.
Published: (2023-07-01)

An IKBKE variant conferring functional cGAS/STING pathway deficiency and susceptibility to recurrent HSV-2 meningitis
by: Azadeh Reyahi, et al.
Published: (2023-11-01)

Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge
by: Annieck M. Diks, et al.
Published: (2023-03-01)

Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
by: Rebecca A. Drummond, et al.
Published: (2022-11-01)

IL-10-producing Th1 cells possess a distinct molecular signature in malaria
by: Chelsea L. Edwards, et al.
Published: (2023-01-01)

Mycobacterium tuberculosis hijacks host TRIM21- and NCOA4-dependent ferritinophagy to enhance intracellular growth
by: Youchao Dai, et al.
Published: (2023-04-01)

Stromal structure remodeling by B lymphocytes limits T cell activation in lymph nodes of Mycobacterium tuberculosis–infected mice
by: Lina Daniel, et al.
Published: (2022-11-01)